Kiniksa Pharmaceuticals International, plc (KNSA)

SEC filing

Kiniksa Pharmaceuticals International, plc

KNSA · CIK 1730430

4 · Sep 3, 2026 · CHIEF OPERATING OFFICER Moat Ross exercised options for 16.57K shares; was granted 46.20K shares; reported 4,007 Class A Ordinary Share

CHIEF OPERATING OFFICER Moat Ross exercised options for 16.57K shares; was granted 46.20K shares; reported 4,007 Class A Ordinary Share

Filed: Sep 3, 2026
Period: Sep 1, 2026
Accession: 0001857177-26-000008
Filer: Kiniksa Pharmaceuticals International, plc

View on SEC.gov All SEC filings

Filing document

xslF345X06/form4-09032026_080952.xml

xslF345X06/form4-09032026_080952.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4form4-09032026_080952.xml
Open SEC.gov